---
title: "Managing Lifecycle Complexity: Controlling Compliance Risk and Operational Pressure Across Regulatory and Pharmacovigilance"
description: "Watch the on-demand recording: Dr. Almudena del Castillo and Joanna Rapacz explore how growing portfolios, acquisitions, and market expansion increase operational complexity across Regulatory Affairs and Pharmacovigilance — and how integrated Lifecycle Management can stabilize operations and control compliance risk."
url: https://qbdgroup.com/en/webinars/managing-lifecycle-complexity-regulatory-pharmacovigilance-on-demand
type: "Webinar"
language: en
published: 2026-06-26
author: "QbD Group"
category: "Regulatory Affairs"
publisher: "QbD Group"
citation: "QbD Group, \"Managing Lifecycle Complexity: Controlling Compliance Risk and Operational Pressure Across Regulatory and Pharmacovigilance\", https://qbdgroup.com/en/webinars/managing-lifecycle-complexity-regulatory-pharmacovigilance-on-demand"
---
# Managing Lifecycle Complexity: Controlling Compliance Risk and Operational Pressure Across Regulatory and Pharmacovigilance
> Watch the on-demand recording: Dr. Almudena del Castillo and Joanna Rapacz explore how growing portfolios, acquisitions, and market expansion increase operational complexity across Regulatory Affairs and Pharmacovigilance — and how integrated Lifecycle Management can stabilize operations and control compliance risk.

_Controlling Compliance Risk and Operational Pressure Across Regulatory and Pharmacovigilance_

In today's pharmaceutical environment, **[Lifecycle Management](https://www.qbdgroup.com/en/industries/medical-devices/life-cycle-management) is no longer only a [regulatory](https://www.qbdgroup.com/en/services/regulatory-affairs) or [pharmacovigilance](https://www.qbdgroup.com/en/services/pharmacovigilance) challenge, it is an operational challenge**.

As organizations grow internationally, add products, integrate acquisitions, or expand into multiple markets, both **[Regulatory Affairs](https://www.qbdgroup.com/en/services/regulatory-affairs) and [Pharmacovigilance](https://www.qbdgroup.com/en/services/pharmacovigilance)** teams face increasing operational complexity. Activities become more interconnected, coordination becomes more difficult, and pressure grows to maintain compliance while controlling workload, timelines, costs, and operational risk.

This webinar explores how these challenges develop across three common operational scenarios:

- Integration of new product types where internal expertise is limited
- Growing portfolios with constrained internal resources
- Expansion into new markets with limited local knowledge or operational capacity

For each scenario, we will connect operational complexity with its impact on **variations, submissions, safety reporting, compliance oversight, and cross-functional coordination**.

The session will also highlight:

- **Loss of control** — Where lifecycle execution typically starts to lose control
- **Emerging risks** — What risks emerge in terms of compliance, timelines, data consistency, and operational efficiency
- **Scalable structure** — How organizations can structure Lifecycle Management activities in a more scalable and cost-efficient way

We will conclude with **case studies** showing how an integrated Lifecycle Management approach helped stabilize operations, reduce complexity, and improve efficiency and cost control across Regulatory and Pharmacovigilance functions.

## What You'll Learn

- How operational complexity, workload, and compliance pressure develop across Regulatory Affairs and Pharmacovigilance activities
- How common business scenarios impact variations, submissions, safety reporting, and cross-functional coordination
- Where Lifecycle Management activities typically become inefficient or difficult to control
- How to improve operational efficiency while maintaining compliance and managing resource constraints
- How integrated Regulatory and PV approaches can support more scalable and cost-efficient operating models
- Practical lessons from real-life cases where Lifecycle Management complexity was successfully managed

## Speakers

### Dr. Almudena del Castillo

**Global Division Head of Drug Safety and Vigilance, QbD Group**

A Medical Doctor and Specialist in Family and Community Medicine, Almudena has built a career spanning pharmacovigilance, regulatory affairs, and drug safety across some of the industry's most prominent organisations, including Pfizer. Before joining QbD Group, she served as VP of Sales and Business Development at Pharmalex and PLG. She is currently Global Division Head of Drug Safety and Vigilance at QbD Group.

### Joanna Rapacz

**RA & CMC Director and Qualified Person, QbD Group**

Joanna brings over 25 years of pharmaceutical industry experience to her role as RA & CMC Director and Qualified Person at QbD Group. Her expertise spans Regulatory Affairs, CMC strategy, GMP quality oversight, and compliance implementation, underpinned by a strong foundation in quality control and R&D. She supports pharmaceutical organisations across the full scope of development and international product authorisation.

## Who Should Attend

This webinar is designed for leaders and professionals responsible for Regulatory Affairs and Pharmacovigilance operations in pharmaceutical organizations facing growing operational complexity.

- Heads, Directors, and Managers of Regulatory Affairs
- Heads, Directors, and Managers of Pharmacovigilance / Drug Safety
- Regulatory Affairs professionals managing variations, submissions, renewals, and post-approval activities
- Pharmacovigilance professionals responsible for safety reporting, compliance oversight, and operational coordination
- Procurement and outsourcing managers involved in vendor selection, operational scalability, and external support models
---
Source: https://qbdgroup.com/en/webinars/managing-lifecycle-complexity-regulatory-pharmacovigilance-on-demand — © QbD Group. Quote freely with attribution and a link back.